Rising Russian Oil Flows to Singapore Trade Not Prohibited Says Ministry Morgan Stanley Highlights Potential Turnaround for Franklin Resources BEN US Productivity Growth Moderates in Q4 as Labor Costs Rise Implications for Inflation and Fed Policy BPs Abrupt Chairman Removal Linked to Alleged Bullying Behavior Company Declines Comment Italys Top Court Rules No Legal Right to Free Tap Water in Hotels Setting Precedent for Hospitality Industry Amazons Dominance in Western ECommerce Why No Rival Has Closed the Gap ODFL Q1 2026 Earnings EPS Surpasses Estimates Amid Steady Operations MCRI Q1 2026 Earnings Strong EPS Beat Drives Positive Market Sentiment GDRX Q1 2026 Earnings EPS Misses Estimates Slightly as Stock Gains Despite Headwinds VLN Q1 2026 Earnings EPS Surprises to the Upside Despite Revenue Uncertainties Rockwell Medical Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges SION Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues RD Investment OXSQG Holds Steady at 2435 as FixedIncome Investors Eye Rate Environment Hycroft Mining HYMC Faces Pressure Testing Key Support at 3070 Cohu Inc COHU Rallies Over 5 as Semiconductor Equipment Demand Trends Improve Cohen Steers Infrastructure Fund UTF Edges Higher as Infrastructure Demand Remains Steady Barrett Business Services BBSI Shows Resilience with 16 Gain as It Approaches Key Resistance Immunic Appoints Erik Lundgren as CEO Amid Phase 3 Multiple Sclerosis Trial Progress AZZ Q1 2026 Earnings Earnings Beat Drives Narrow Stock Move Agilent Technologies A Holds Steady as Stock Trades Near Midpoint of Trading Range AVNS Q1 2026 Earnings EPS Surges Past Estimates by 54 ALCO Q1 2026 Earnings Robust EPS Beat on Strong Operational Execution Ocugen Inc OCGN Q1 2026 Earnings Wider Loss Misses Estimate as PreRevenue Biotech Focuses on Pipeline HL Q1 2026 Earnings EPS Misses Estimates Shares Rise Despite Surprise KINS Q1 2026 Earnings EPS Misses Estimates Amid Challenging Underwriting Environment OPLN Q1 2026 Earnings EPS Beats Estimates by 124 Stock Rises Telomir Pharmaceuticals Inc TELO Q4 2025 Earnings WiderthanExpected Loss Highlights DevelopmentStage Challenges